Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 11 for:    "Otic Pharma" OR "Novus Therapeutics" OR "Tokai Pharmaceuticals"

Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02729376
Recruitment Status : Completed
First Posted : April 6, 2016
Last Update Posted : April 27, 2016
Sponsor:
Information provided by (Responsible Party):
Novus Therapeutics, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2016
Actual Study Completion Date : April 2016